Waqas Arshad

Sensorineural hearing loss (SNHL) is one of the most prevalent sensory deficits worldwide, affecting hundreds of millions of individuals across all age groups. Caused by structural or functional impairment of the inner ear’s delicate hair cells, the auditory nerve, or central auditory processing pathways, SNHL presents a profound biological and clinical challenge. While genetic mutations … Read more

Whether it originates from a well-meaning parent, a concerned partner, or a public health campaign, nagging about food is a universal experience. We have all heard the persistent reminders: “Finish your broccoli,” “Are you really going to eat that second slice of pizza?”, or “You need to cut out carbs.”  Despite good intentions, behavioral psychology and … Read more

In the age of hyper-connected social media, public health events and scientific breakthroughs are frequently woven together into intricate online narratives. A prominent rumor circulated across digital platforms alleging that the development of an advanced mRNA plague vaccine by Israeli researchers was suspiciously timed to coincide with the death of a laboratory worker at a … Read more

Across Europe and North America, public health surveillance systems are monitoring a troubling shift in the illicit drug market. In Scotland, a synthetic veterinary sedative known as medetomidine has emerged as a major contaminant in street drugs. Originally formulated strictly for veterinary medicine to sedate animals such as cats, dogs, and horses, medetomidine is increasingly being … Read more

During a public rally in Ohio, former U.S. President Donald Trump addressed ongoing health speculation by making a surprising disclosure about his daily medication routine. Disregarding recommendations from medical staff to take a standard low-dose regimen, Trump disclosed that he insists on taking high-dose Bayer aspirin (325 mg to 386 mg daily)—a pill he characterized … Read more

In a transformative move for the molecular imaging industry, GE HealthCare announced a definitive all-cash agreement to acquire SOFIE Biosciences from Trilantic North America for $945 million. This strategic acquisition secures a vital U.S. manufacturing footprint for Positron Emission Tomography (PET) radiopharmaceuticals, expanding GE HealthCare’s Pharmaceutical Diagnostics (PDx) segment and reinforcing its leadership in precision … Read more

President Donald J. Trump sparked widespread discussion across economic, political, and medical sectors by asserting that medical technology giant Becton, Dickinson and Company (BD) agreed to invest $3 billion in U.S. manufacturing—including over $1 billion earmarked for facilities in Nebraska—specifically in response to upcoming, aggressive import tariffs on medical devices scheduled for implementation by the … Read more

Receiving a diagnosis of type 2 diabetes often feels like managing a single health metric: blood glucose. Many patients focus exclusively on daily finger pricks, fasting blood sugar numbers, and maintaining an acceptable Hemoglobin A1c (HbA1c). However, long-term clinical observational data underscores a sobering reality. Within ten years of a type 2 diabetes diagnosis, a … Read more

Every second, trillions of biochemical interactions occur within your body to maintain a state of equilibrium known as homeostasis. Underneath this quiet harmony lies a complex system of genetic instructions. Occasionally, a key gene undergoes a mutation, transforming from a benevolent biological instruction into an oncogene—a potential catalyst for cancer. When an oncogene such as … Read more